SUVENPHAR Suven Pharmaceuticals Ltd Company Mergers Announcement 2024 - Acquisition Announcement Suven Pharmaceuticals intends to acquire a majority stake in NJ Bio, Inc., a US-based antibody drug conjugate company with $32 million in revenue and over 500 delivered projects in the last five years..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Suven Pharmaceuticals Ltd